Study #2021-0353
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
MD Anderson Study Status
Not Accepting
Treatment Agent
AL102
Description
The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Desmoid, Desmoid Tumor
Study phase:
Phase II/III
Physician name:
Ravin Ratan
Department:
Sarcoma Medical Oncology
For general questions about clinical trials:
1-855-807-9574
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.